Paulo F. Costa's most recent trade in CorMedix Inc was a trade of 10,000 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on May 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Paulo F. Costa | Director | Purchase of securities on an exchange or from another person at price $ 4.65 per share. | 17 May 2023 | 10,000 | 10,000 (0%) | 0% | 4.7 | 46,500 | Common Stock |
| CorMedix Inc | Paulo F. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Paulo F. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Macrogenics Inc | Paulo F. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| CorMedix Inc | Paulo F. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) |